Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PEP
|
Albert P Carey
CEO, North America |
BUY
Grant, award, or other acquisition
|
Direct | 5,830 Added 2.34% |
-
|
Apr 02
2015 |
|
PEP
|
Indra K Nooyi
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 73,225 Reduced 9.21% |
$6,982,004
$95.35 p/Share
|
Apr 02
2015 |
|
PEP
|
Indra K Nooyi
Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 28,029 Added 3.41% |
-
|
Apr 02
2015 |
|
PEP
|
Mehmood Khan
Vice Chair,EVP,CSO,Global R&D |
SELL
Payment of exercise price or tax liability
|
Direct | 10,426 Reduced 6.17% |
$994,119
$95.35 p/Share
|
Apr 02
2015 |
|
PEP
|
Mehmood Khan
Vice Chair,EVP,CSO,Global R&D |
BUY
Grant, award, or other acquisition
|
Direct | 4,036 Added 2.33% |
-
|
Apr 02
2015 |
|
PEP
|
Thomas Greco
CEO, FLNA |
SELL
Payment of exercise price or tax liability
|
Direct | 7,286 Reduced 5.02% |
$694,720
$95.35 p/Share
|
Apr 02
2015 |
|
PEP
|
Thomas Greco
CEO, FLNA |
BUY
Grant, award, or other acquisition
|
Direct | 3,364 Added 2.27% |
-
|
Apr 02
2015 |
|
PEP
|
Sanjeev Chadha
Chairman, AMENA |
SELL
Payment of exercise price or tax liability
|
Direct | 1,857 Reduced 1.48% |
$177,065
$95.35 p/Share
|
Apr 02
2015 |
|
PEP
|
Sanjeev Chadha
Chairman, AMENA |
BUY
Grant, award, or other acquisition
|
Direct | 1,159 Added 0.92% |
-
|
Apr 02
2015 |
|
PEP
|
Ramon Laguarta
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,801 Reduced 3.56% |
$457,775
$95.35 p/Share
|
Apr 02
2015 |
|
PEP
|
Ramon Laguarta
Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 938 Added 0.69% |
-
|
Apr 02
2015 |
|
PEP
|
Cynthia Trudell
EVP, HR & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 9,157 Reduced 14.92% |
$873,120
$95.35 p/Share
|
Apr 02
2015 |
|
PEP
|
Cynthia Trudell
EVP, HR & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,610 Added 5.56% |
-
|
Apr 02
2015 |
|
PEP
|
Enderson Guimaraes
EVP, Global Categories & Ops. |
BUY
Grant, award, or other acquisition
|
Direct | 3,223 Added 2.37% |
-
|
Apr 02
2015 |
|
PEP
|
Enderson Guimaraes
EVP, Global Categories & Ops. |
SELL
Payment of exercise price or tax liability
|
Direct | 8,583 Reduced 6.46% |
$818,389
$95.35 p/Share
|
Apr 02
2015 |
|
DJCO
|
John Patrick Et Al Guerin
Director |
SELL
Open market or private sale
|
Indirect | 474 Reduced 0.3% |
$87,690
$185.0 p/Share
|
Apr 02
2015 |
|
ADBE
|
Donna Morris
EVP, CHRO, Employee Experience |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 10.37% |
$756,400
$75.64 p/Share
|
Apr 02
2015 |
|
SNPS
|
Alfred Castino
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 6.23% |
-
|
Apr 02
2015 |
|
SNPS
|
Janice Chaffin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 50.0% |
-
|
Apr 02
2015 |
|
SNPS
|
Bruce R Chizen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 8.7% |
-
|
Apr 02
2015 |
|
SNPS
|
Deborah A Coleman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 5.59% |
-
|
Apr 02
2015 |
|
SNPS
|
Chrysostomos L Nikias
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 14.97% |
-
|
Apr 02
2015 |
|
SNPS
|
John Schwarz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 6.99% |
-
|
Apr 02
2015 |
|
SNPS
|
Roy Vallee
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 4.64% |
-
|
Apr 02
2015 |
|
SNPS
|
Steven Walske
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,690 Added 8.16% |
-
|
Apr 02
2015 |
|
CVS
|
Lisa Bisaccia
Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,862 Reduced 6.05% |
$191,246
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
Andrew Sussman
EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct | 1,596 Reduced 10.27% |
$163,925
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
Helena Foulkes
EVP & President-CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct | 2,394 Reduced 7.31% |
$245,888
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
Larry J Merlo
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 19,944 Reduced 10.99% |
$2,048,448
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
Jonathan C Roberts
EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,654 Reduced 8.2% |
$478,012
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
David M Denton
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 6,648 Reduced 5.59% |
$682,816
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 16,637 Added 17.49% |
$749,830
$45.07 p/Share
|
Apr 02
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,989 Reduced 6.06% |
$409,710
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 16,637 Reduced 21.2% |
$1,708,786
$102.71 p/Share
|
Apr 02
2015 |
|
CVS
|
J. David Joyner
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,862 Reduced 3.15% |
$191,246
$102.71 p/Share
|
Apr 02
2015 |
|
AAPL
|
Angela J Ahrendts
Senior Vice President |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 20.04% |
$3,127,000
$125.08 p/Share
|
Apr 02
2015 |
|
LGF-B
|
Jon Feltheimer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 185,600 Reduced 11.69% |
$6,238,016
$33.61 p/Share
|
Apr 02
2015 |
|
ORCL
|
Safra Catz
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 250,000 Added 48.78% |
$3,642,500
$14.57 p/Share
|
Apr 02
2015 |
|
CVS
|
Stephen J Gold
EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct | 5,867 Added 13.56% |
$599,959
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Lisa Bisaccia
Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,889 Added 15.33% |
$499,949
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Andrew Sussman
EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct | 3,422 Added 16.79% |
$349,934
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Andrew Sussman
EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct | 3,086 Reduced 20.17% |
$315,574
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Helena Foulkes
EVP & President-CVS Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct | 8,556 Added 16.71% |
$874,937
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Larry J Merlo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 39,115 Added 14.01% |
$3,999,900
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Jonathan C Roberts
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,778 Added 14.27% |
$999,898
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
David M Denton
EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 8,556 Added 4.63% |
$874,937
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,234 Reduced 3.74% |
$228,449
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 16,747 Reduced 22.55% |
$1,712,548
$102.26 p/Share
|
Apr 01
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 16,747 Added 18.4% |
$585,475
$34.96 p/Share
|
Apr 01
2015 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,845 Added 13.5% |
$699,970
$102.26 p/Share
|
Apr 01
2015 |